| __timestamp | Neurocrine Biosciences, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 14400000 | 125883000 |
| Thursday, January 1, 2015 | 33800000 | 69036000 |
| Friday, January 1, 2016 | 35900000 | 72700000 |
| Sunday, January 1, 2017 | 1254000 | 105700000 |
| Monday, January 1, 2018 | 4889000 | 198700000 |
| Tuesday, January 1, 2019 | 7400000 | 117600000 |
| Wednesday, January 1, 2020 | 10100000 | 108100000 |
| Friday, January 1, 2021 | 14300000 | 122500000 |
| Saturday, January 1, 2022 | 23200000 | 146700000 |
| Sunday, January 1, 2023 | 39700000 | 257500000 |
| Monday, January 1, 2024 | 34000000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, understanding cost structures is crucial. This analysis delves into the cost of revenue trends for United Therapeutics Corporation and Neurocrine Biosciences, Inc. over the past decade. From 2014 to 2023, United Therapeutics consistently outpaced Neurocrine in cost of revenue, peaking in 2023 with a staggering 257% increase from its 2015 low. Meanwhile, Neurocrine's cost of revenue saw a dramatic rise, culminating in a 175% increase by 2023 compared to its 2014 figures. This divergence highlights differing strategic approaches: United Therapeutics' steady growth versus Neurocrine's more volatile trajectory. Such insights are invaluable for investors and industry analysts seeking to understand the financial dynamics driving these biotech leaders.
Cost of Revenue Comparison: AbbVie Inc. vs Neurocrine Biosciences, Inc.
Sanofi vs United Therapeutics Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: United Therapeutics Corporation vs Insmed Incorporated
Cost Insights: Breaking Down United Therapeutics Corporation and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for United Therapeutics Corporation and Bausch Health Companies Inc.
Cost of Revenue Comparison: United Therapeutics Corporation vs Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for United Therapeutics Corporation and Galapagos NV
Neurocrine Biosciences, Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Telix Pharmaceuticals Limited
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Mesoblast Limited